MAM-1003-1

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug NameMAM-1003-1
Drug Alias NameTacrolimus Eye DropsTacrosolvMAM-1003-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalcineurin inhibitorsCytokines inhibitorsImmunosuppressants +[5] 
TargetsCalcineurinFK506-binding protein 1ACytokines +[4] 
Therapy Area/IndicationsConjunctivitis, AllergicRhinitis, Allergic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMarinomed Biotech AG
China Registration ClassN/A

Develop Information

Active CompaniesMarinomed Biotech AG
Inactive CompaniesN/A
Active IndicationsConjunctivitis, AllergicRhinitis, Allergic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A